Dow Turns Higher; Gold Down 1%
U.S. stocks pared losses, with the Dow Jones turning higher toward the end of trading on Thursday.
Psychedelics Funding At Its Best: $1.5M Destined To Psilocin Clinical Trials In Australia
Psychedelics biopharma company Lobe Sciences Ltd.
Nasdaq Tumbles 250 Points; Crude Oil Falls Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 250 points on Thursday
US Stocks Start September On A Weak Note After Recording Losses For Four Straight Sessions
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Thursday
China Locks Down 21M Chengdu Residents As COVID-19 Cases Spur In Megacity
China has locked down about 21.2 million residents of one of its biggest cities, Chengdu, amid rising COVID-19 cases.
What Happened: The authorities have asked all its residents in Sichuan’s Chengdu to stay mostly at home, starting 6 p.m. on Thursday, as it launched a four-day citywide COVID-19 testing drive.
Nasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsy
Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
Mindset Pharma Inc. (OTCQB: MSSTF), a company producing psychedelic and non-psychedelic drugs for mental health conditions has recently identified three additional families of highly novel, non-tryptamine psychedelic compounds.
Nasdaq Edges Higher; Bed Bath & Beyond Shares Plunge
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping more than 100 points on Wednesday